Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

2'-O-methyl phosphorothioate RNA oligonucleotide, 5'-m5CUGm5CUGm5CUGm5CUGm5CUGm5CUGm5CUG-3'

EU orphan designation number: EU/3/15/1432   
Active ingredient: 2'-O-methyl phosphorothioate RNA oligonucleotide, 5'-m5CUGm5CUGm5CUGm5CUGm5CUGm5CUGm5CUG-3'
Indication: Treatment of Huntington's disease
Sponsor: BioMarin International Limited
6th Floor, 2 Grand Canal Square, Dublin 2, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/02/2015 Orphan designation EMA/OD/192/14 (2015)1274 of 18/02/2015
9/06/2015 Transfer of orphan designation EMA/OD/192/14/T/01 (2015)3934 of 5/06/2015
1/12/2016 Change of name and/or address of sponsor